Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.4.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.4.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.4.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.103EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.103EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.103ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.103ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.103EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.103EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.103ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.103ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.89EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.89ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.89ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.89EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.89EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.89ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.89ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HR.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HR.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HR.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HR.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HP.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HP.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HP.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HP.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HP.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HP.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GW.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GW.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GW.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GW.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GW.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GW.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used